According to Valuates Reports, The global market for AI in Biotechnology was valued at USD 1033 Million in the year 2024 and ...
NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Fusemachines Inc. (“Fusemachines” or the “Company”) (NASDAQ: FUSE), a leading ...
Dr Michael Chen, CEO and co‑founder of Nuclera, said: “Scientists are under pressure to progress increasingly complex membrane protein programs faster. By partnering with leadXpro, we can pair ...
After seven years and $30 million invested in clinical AI research, CEO Grace Chang reveals the steep economics of building ...
Have you ever seen a hibiscus flower? Although its petals have a range of colors, what makes the trumpet-shaped flower more ...
News Medical on MSN
Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins
Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in ...
Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a drug discovery company developing breakthrough medicines through AI-enhanced computational chemistry, today announced that it will ...
Ocwen Financial Corporation (NYSE:OCN) Q4 2025 Earnings Call Transcript February 12, 2026 Operator: Thank you for your ...
Today Cyberstar, the cyber workforce management platform purpose-built for defense and federal organizations, and Pluralsight, the leading technology skills development company, announces a strategic ...
OneFii deploys customized AI-native enterprise systems for businesses, enabling 24/7 autonomous operations, scalable ...
The Victory Sophus Emerging Markets Fund outperformed its benchmark in Q4 2024 despite global volatility. Read the full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results